|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:L465905 |
| 產(chǎn)品名稱:Linagliptin Impurity |
| 產(chǎn)品CAS: |
| 規(guī)格含量:100mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
L465905 |
| 名稱: |
Linagliptin Impurity |
| 別名: |
(R)-7-(But-2-yn-1-yl)-3-methyl-8-(3-(((4-methylquinazolin-2-yl)methyl)amino)piperidin-1-yl)-1H-purine-2,6(3H,7H)-dione; |
| 分子式: |
C??H??N?O? |
| 分子量: |
472.54 |
| 種類: |
Research Tools; |
| 應(yīng)用: |
Linagliptin Impurity, is a new potent DPP-4 inhibitors structurally derived form the xanthine scaffold for the treatment of type 2 diabetes. |
| 參考文獻(xiàn) |
|
|
|
|